The Pivot of FDI in Indian Pharma
The department of industrial policy promotion (DIPP) is bringing new headwinds to the FDI (Foreign Direct Investment) in the sector of pharmaceuticals that looking for a review from it in regarding policies barely after its intervention from prime minister Clearance in months.
The controversy rises here is regarding the FDI in retail to kick up the retail industry might bump back for time being, whereas another sector pharmaceuticals from FDI is quietly comes for UPA government clearance, which is going to hit common man pocket in future.
States in India have some patent rights on the investor’s expenditure that spent on innovative research resources. These rights are granted for a certain period and during this period the owner solely can manufacture the drug by finding and fixing price...
